Immunocore Holdings Statistics
Total Valuation
IMCR has a market cap or net worth of $2.88 billion. The enterprise value is $2.44 billion.
Market Cap | 2.88B |
Enterprise Value | 2.44B |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
IMCR has 49.73 million shares outstanding.
Shares Outstanding | 49.73M |
Owned by Insiders (%) | 9.97% |
Owned by Institutions (%) | 84.11% |
Float | 32.44M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.56 |
Forward PS | 10.58 |
PB Ratio | 6.25 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 9.76 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.23.
Current Ratio | 3.80 |
Quick Ratio | 3.56 |
Debt / Equity | 0.23 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -10.81 |
Financial Efficiency
Return on equity (ROE) is -15.50% and return on invested capital (ROIC) is -13.17%.
Return on Equity (ROE) | -15.50% |
Return on Assets (ROA) | -9.80% |
Return on Capital (ROIC) | -13.17% |
Revenue Per Employee | $501,867 |
Profits Per Employee | -$111,241 |
Employee Count | 497 |
Asset Turnover | 0.44 |
Inventory Turnover | 0.40 |
Taxes
Income Tax | -7.01M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.48% in the last 52 weeks. The beta is 0.89, so IMCR's price volatility has been lower than the market average.
Beta (1Y) | 0.89 |
52-Week Price Change | -4.48% |
50-Day Moving Average | 62.71 |
200-Day Moving Average | 59.64 |
Relative Strength Index (RSI) | 45.44 |
Average Volume (30 Days) | 504,179 |
Short Selling Information
Short Interest | 4.09M |
Short Previous Month | 4.61M |
Short % of Shares Out | 9.32% |
Short % of Float | n/a |
Short Ratio (days to cover) | 10.64 |
Income Statement
In the last 12 months, IMCR had revenue of $249.43 million and -$55.29 million in losses. Loss per share was -$1.41.
Revenue | 249.43M |
Gross Profit | 310.78M |
Operating Income | -74.63M |
Pretax Income | -76.18M |
Net Income | -55.29M |
EBITDA | -62.56M |
EBIT | -69.74M |
Loss Per Share | -$1.41 |
Balance Sheet
The company has $553.81 million in cash and $105.14 million in debt, giving a net cash position of $448.67 million or $9.02 per share.
Cash & Cash Equivalents | 553.81M |
Total Debt | 105.14M |
Net Cash | 448.67M |
Net Cash Per Share | $9.02 |
Equity / Book Value | 461.49M |
Book Value Per Share | 9.28 |
Working Capital | 487.71M |
Cash Flow
In the last 12 months, operating cash flow was $3.68 million and capital expenditures -$6.79 million, giving a free cash flow of -$3.11 million.
Operating Cash Flow | 3.68M |
Capital Expenditures | -6.79M |
Free Cash Flow | -3.11M |
FCF Per Share | -$0.06 |
Margins
Gross margin is 124.60%, with operating and profit margins of -29.92% and -22.17%.
Gross Margin | 124.60% |
Operating Margin | -29.92% |
Pretax Margin | -30.54% |
Profit Margin | -22.17% |
EBITDA Margin | -25.08% |
EBIT Margin | -27.96% |
FCF Margin | -1.25% |
Dividends & Yields
IMCR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.94% |
Shareholder Yield | -6.94% |
Earnings Yield | -1.92% |
FCF Yield | -0.11% |
Analyst Forecast
The average price target for IMCR is $82.50, which is 42.24% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $82.50 |
Price Target Difference | 42.24% |
Analyst Consensus | Strong Buy |
Analyst Count | 13 |
Revenue Growth Forecast (5Y) | 20.97% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
IMCR has an Altman Z-Score of 5.12 and a Piotroski F-Score of 3.
Altman Z-Score | 5.12 |
Piotroski F-Score | 3 |